Showing results (351-360 of 373) with videos related to
Sort By:
Pageof 38
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2019
Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South AfricaTyler S Brown, Lavanya Challagundla, Evan H Baugh, et al.The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort StudyNicholas E Khan, Andrew J Bauer, Kris Ann P Schultz, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variationKris Ann P Schultz, Alexander Nelson, Anne K Harris, et al.JAMA Network Open|February 25, 2021
A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and PhenotypeUyenlinh L Mirshahi, Jung Kim, Ana F Best, et al.Cancer|December 21, 2022
Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 RegistryAlexander T Nelson, Anne K Harris, Dave Watson, et al.Emerging Infectious Diseases|February 6, 2020
Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018Aisling Vaughan, Emma Aarons, John Astbury, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 2012
Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureusPaul R McAdam, Kate E Templeton, Giles F Edwards, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2022
Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/DICER1 RegistryKris Ann P Schultz, Anne K Harris, Alexander T Nelson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2018
DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance StrategiesKris Ann P Schultz, Gretchen M Williams, Junne Kamihara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Irinotecan therapy in adults with recurrent or progressive malignant gliomaH S Friedman, W P Petros, A H Friedman, et al.Pageof 38